Study probes Epinephrine's role in blood vessel health

NCT ID NCT02692313

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This completed early-phase study looked at how epinephrine (adrenaline) affects blood vessel function and clotting in 32 healthy adults. Researchers gave participants epinephrine or a placebo and measured changes in artery dilation. The goal was to better understand why people with diabetes face higher heart risks, but the study did not involve diabetes patients.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Epinephrine (adrenaline)
What this could lead to
If successful, this study could help explain how the body's response to low blood sugar affects blood vessels, potentially pointing toward ways to prevent heart problems in people with diabetes.
What could go wrong
This is a very early study in only 32 healthy people, not those with diabetes. It measures temporary changes in blood vessel function, not long-term health outcomes, so results may not apply to real-world diabetes care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetes Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Maryland, Baltimore

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.